Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 9 of 14, showing 10 Applications out of 133 total, starting on record 81, ending on 90

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

81.

ECCT/22/10/05   Agios Study
    A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease. Mitapivat - AG348-C-020   
Principal Investigator(s)
1. Videlis N Nduba
Site(s) in Kenya
1. KEMRI/CRDR (Nairobi City county)
2. KEMRI Siaya Clinical Research Annex (Siaya county)
 
26-02-2023 View

82.

ECCT/25/09/03   PRESERVE
    Partial breast re-irradiation using ultra hypofractionation (PRESERVE) Phase 2 multi-institutional study   
Principal Investigator(s)
1. Angela Waweru
Site(s) in Kenya
Aga Khan University Hospital
 
09-02-2026 View

83.

ECCT/18/04/01   CKAF156 STUDY
    A Phase 2 interventional, multicenter, randomized open-label study to determine the effective and tolerable dose of KAF156 and Lumefantrine Solid Dispersion Formulation in combination, given once daily for 1, 2 and 3-days to adults and children with uncomplicated Plasmodium falciparum malaria.   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. KEMRI CDC (Siaya county)
2. Walter Reed Project (Kisumu county)
 
23-08-2018 View

84.

ECCT/21/02/04   GASTROSAM
     GASTROSAM   Gastroenteritis: Rehydration of children with severe acute malnutrition   
Principal Investigator(s)
1. Professor Kathryn Maitland
Site(s) in Kenya
Kilifi County Hospital
 
13-05-2021 View

85.

ECCT/11/08/05   Rifapentine During Intensive Phase TB Treatment
        Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis   
Principal Investigator(s)
1. Lena Matata
2. Kevin Cain
Site(s) in Kenya
KEMRI/CDC-KISUMU
 
02-11-2011 View

86.

ECCT/13/01/01  
        An Open Label Randomized Controlled Phase IIb Trial to Determine the Safety of Oral Fluconazole in Combination with Flucytosine as Compared to Fluconazole Alone   
Principal Investigator(s)
1. Ana-Claire Meyer
2. Judith Kwasa
3. Mark Jacobson
Site(s) in Kenya
1. Family AIDS Care and Education Services, Lumumba Health Center (Kisumu county)
2. Family AIDS Care and Education Services, Suba District Hospital (Homa Bay county)
 
05-01-2013 View

87.

ECCT/23/10/07   Fermented Food and Prediabetes
        A Study of the Hypoglycemic Effect of African Traditonal Fermented Foods amongst Prediabetic Adults.   
Principal Investigator(s)
1. Rosebella Iseme - Ondiek
Site(s) in Kenya
1. Aga Khan Outreach Centre Nairobi CBD/Town (Nairobi City county)
2. Aga Khan Outreach Centre Valley Arcade (Nairobi City county)
3. Aga Khan Outreach Centre Capital Centre (Nairobi City county)
4. Aga Khan Outreach Centre Kiambu Town (Kiambu county)
5. Aga Khan Outreach Centre Juja (Kiambu county)
6. Aga Khan Outreach Centre Ruiru (Kiambu county)
7. Aga Khan Outreach Centre Ongata Rongai (Kajiado county)
8. Aga Khan Outreach Centre Ngong (Kajiado county)
9. Aga Khan Outreach Centre Kitengela (Kajiado county)
 
17-01-2024 View

88.

ECCT/15/06/04   A5316
        A5316           Evaluating Pharmacokinetic Interactions with Vaginal Ring Contraceptives and Antiretroviral Therapy   
Principal Investigator(s)
1. Dr. Esther Mumbi Makanga Makanga
2. Dr. Victor Akelo Akelo
3. Dr.Victor O. Mudhune Mudhune
4. Dr. Kevin P. Cain Cain
Site(s) in Kenya
KEMRI- CDC
 
17-07-2015 View

89.

ECCT/22/02/02   The Women TAF-FTC Benchmark
    Safety and Pharmacokinetics of TAF-FTC Pre-exposure Prophylaxis in Kenyan Cisgender women   
Principal Investigator(s)
1. Dr. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR PHRD Thika
 
18-11-2022 View

90.

ECCT/13/02/01   AMC 068
    A Randomized Phase II Trial Of Chop Vs Oral Chemotherapy with Concomitant Antiretroviral Therapy in Patients with HIV-Associated Lymphoma in Sub-Saharan Africa   
Principal Investigator(s)
1. NAFTALI WISINDI BUSAKHALA
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTER
 
22-11-2012 View